Apolipoprotein Polymorphisms and Risk of Coronary Heart Disease

NCT00005225 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-01-21

No results posted yet for this study

Summary

To determine the relative risk in a defined population of angiographically demonstrated coronary artery disease due to genetic polymorphisms at the four apolipoprotein genomic regions.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • University of Utah

    lead OTHER

Eligibility

Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1988-04-30
Completion
1991-03-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005225 on ClinicalTrials.gov